ETFdb Logo
ETFdb Logo
  • ETF Database
  • Channels
    • Active ETF
    • Beyond Basic Beta
    • China Insights
    • Climate Insights
    • Commodities
    • Core Strategies
    • Crypto
    • Direct Indexing
    • Disruptive Technology
    • Energy Infrastructure
    • ETF Building Blocks
    • ETF Education
    • ETF Strategist
    • Financial Literacy
    • Fixed Income
    • Gold/Silver/Critical Minerals
    • Innovative ETFs
    • Institutional Income Strategies
    • Leveraged & Inverse
    • Managed Futures
    • Market Insights
    • Modern Alpha
    • Night Effect
    • Portfolio Strategies
    • Responsible Investing
    • Retirement Income
    • Richard Bernstein Advisors
    • Tax Efficient Income
    • Volatility Resource
  • Tools
    • ETF Screener
    • ETF Country Exposure Tool
    • ETF Sector Tracker Tool
    • ETF Database Categories
    • Head-To-Head ETF Comparison Tool
    • ETF Stock Exposure Tool
    • ETF Issuer Fund Flows
    • Indexes
    • Mutual Fund To ETF Converter
  • Research
    • ETF Education
    • Equity Investing
    • Dividend ETFs
    • Leveraged ETFs
    • Inverse ETFs
    • Index Education
    • Index Insights
    • Top ETF Sectors
    • Top ETF Issuers
    • Top ETF Industries
  • Webcasts
  • Themes
    • AI ETFs
    • Blockchain ETFs
    • See all Thematic Investing ETF themes
    • ESG Investing
    • Marijuana ETFs
  • Multimedia
    • ETF 360 Video Series
    • ETF of the Week Podcast
    • ETF Prime Podcast
    • Video
  • Company
    • About VettaFi
    • Get VettaFi’ed
  • PRO
    • Pro Content
    • Pro Tools
    • Advanced
    • FAQ
    • Pricing
    • Free Sign Up
    • Login
  1. Portfolio Strategies Channel
  2. Top Healthcare Companies Reside in This ETF
Portfolio Strategies Channel
Share

Top Healthcare Companies Reside in This ETF

Tom LydonApr 21, 2023
2023-04-21

While still sporting a modest year-to-date loss, the S&P 500 Health Care Index is higher by 4.44% over the past month, and with the healthcare sector’s reputation for defensive and quality traits, it could be a refuge for market participants if broader market volatility creeps higher.

Plus, there’s value to be had in the sector, potentially increasing the allure of exchange traded funds such as the Invesco S&P 500® Equal Weight Health Care ETF (RYH A-). Speaking of value, RYH is proving the value of equal-weight as it pertains to healthcare stocks. The Invesco ETF is higher by 3.16% year-to-date while the cap-weighted S&P 500 Health Care Index is lower by almost 2%.

As an equal-weight ETF, RYH offers investors the diversification they’d expect with such a strategy. For example, none of the fund’s 66 holdings exceed a weight of 1.89%. That diversification makes RYH a potentially pertinent choice for investors seeking a broad-based play on some of the best healthcare equities — a theme recently highlighted by Morningstar.

Blue-chip pharmaceuticals companies Dow component Johnson & Johnson (JNJ) and Pfizer (PFE) are among the names on that list. Both are RYH components.

J&J sports an attractive wide moat, which “supported by intellectual property in the drug group … and strong brand power from the consumer group. Despite carrying some lower-margin divisions, J&J maintains strong pricing power and has posted gross margins above 70% during the past four years, validating its strong competitive position,” noted Morningstar analyst Damien Conover.

Of note is the fact that RYH allocates nearly a third of its weight to medical device manufacturers, giving the ETF a  different industry profile than its biotech/pharma-heavy cap-weighted rivals. That’s worth mentioning because the medical device industry is littered with wide moat firms, including several that are RYH holdings.

“Medical devices, for their part, have high switching costs because surgeons develop expertise in using a differentiated set of tools and device systems have component parts that are designed to work together,” according to Morningstar.

RYH member firms Zimmer Biomet Holdings (ZBH) and Thermo Fisher Scientific (TMO) are examples of medical device companies with switching cost advantages. In other words, yes, these companies have competitors, but it can be costly and time-consuming for hospitals to leave these companies for rivals.

Nearly all RYH components sport intangible assets advantages, while others combine that traits with pure-cost and switching-cost advantages.

For more news, information, and analysis, visit our Portfolio Strategies Channel.

Loading Articles...
Our Sites
  • VettaFi
  • Advisor Perspectives
  • ETF Trends
Tools
  • ETF Screener
  • Mutual Fund to ETF Converter
  • Head-To-Head ETF Comparison
  • ETF Country Exposure Tool
  • ETF Stock Exposure Tool
  • ETF Database Pro
More Tools
  • Financial Advisor & RIA Center
Explore ETFs
  • ETF News
  • ETF Category Reports
  • Premium Articles
  • Alphabetical Listing of ETFs
  • Browse ETFs by ETF Database Category
  • Browse ETFs by Index
  • Browse ETFs by Issuer
  • Compare ETFs
Information
  • Contact Us
  • Terms of Use and Privacy Policy
  • © 2023 VettaFi LLC. All rights reserved.

Advertisement

Is Your Portfolio Positioned With Enough Global Exposure?

ETF Education Channel

How to Allocate Commodities in Portfolios

Tom LydonApr 26, 2022
2022-04-26

A long-running debate in asset allocation circles is how much of a portfolio an investor should...

Core Strategies Channel

Why ETFs Experience Limit Up/Down Protections

Karrie GordonMay 13, 2022
2022-05-13

In a digital age where information moves in milliseconds and millions of participants can transact...

}
X